BeOne Medicines (ONC) Cash from Operations Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 74.39% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 3.23% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 158.60% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 356.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 356.73% |
| Dec 31, 2025 | 455.28% |
| Sep 30, 2025 | 113.70% |
| Jun 30, 2025 | 375.76% |
| Mar 31, 2025 | 114.29% |
| Dec 31, 2024 | 133.91% |
| Sep 30, 2024 | 341.04% |
| Jun 30, 2024 | 67.47% |
| Mar 31, 2024 | 45.27% |
| Dec 31, 2023 | 30.34% |
| Sep 30, 2023 | 86.09% |
| Jun 30, 2023 | 22.65% |
| Mar 31, 2023 | -138.32% |
| Dec 31, 2022 | -350.36% |
| Sep 30, 2022 | -13.35% |
| Jun 30, 2022 | 9.59% |
| Mar 31, 2022 | -289.11% |
| Dec 31, 2021 | 138.24% |
| Sep 30, 2021 | -43.17% |
| Jun 30, 2021 | -59.83% |
| Mar 31, 2021 | 136.58% |
| Dec 31, 2020 | -24.39% |
| Sep 30, 2020 | -30.65% |
| Jun 30, 2020 | -470.36% |
| Mar 31, 2020 | -98.83% |
| Dec 31, 2019 | -37.80% |
| Sep 30, 2019 | -100.49% |
| Jun 30, 2019 | 60.64% |
| Mar 31, 2019 | -64.57% |
| Dec 31, 2018 | -306.82% |
| Sep 30, 2018 | -2,102.80% |
| Jun 30, 2018 | -125.76% |
| Mar 31, 2018 | -192.63% |
| Dec 31, 2017 | 458.64% |
| Sep 30, 2017 | 127.19% |
| Jun 30, 2017 | -169.45% |
| Mar 31, 2017 | -79.99% |
| Dec 31, 2016 | -55.95% |
| Sep 30, 2016 | -145.73% |
| Jun 30, 2016 | -102.89% |
| Mar 31, 2016 | -434.65% |